SDG3. Working to ensure healthy lives and promote well-being for all at all ages
The Agenda 2030 and its 17 Sustainable Development Goals (SDGs), approved in 2015 by the United Nations, define a set of very ambitious goals for the year 2030. A universal call for action was made to all countries, governments, businesses, civil society and individuals. The reason? There is an urgency for change with regards to people’s quality of life including education, health, equality as well as the recovery and protection of our planet and its ecosystems. We only have 9 years to reach these goals and we ALL have a hard work to do!
At Strata we take the importance of the UN SDGs very seriously and are committed to contributing to them working along with start-ups and SMEs to bring innovative and sustainable products and services to the market. As a team of engineers, innovators and scientists, we believe that technology alone won’t make all the work but will play a critical role in making possible the changes that our world needs. That’s why at Strata we only work on projects that are aligned with one or more SDG goals.
Startups and technology will play a critical role
Looking at Sustainable Goal 3, more specific sub-targets such as 3.2. are included: “By 2030, end preventable deaths of new-borns and children under 5 years of age, with all countries aiming to reduce neonatal mortality”. Approximately, 15 million babies are born prematurely every year worldwide and the numbers are expected to rise. We are glad to collaborate with Oxyprem in dealing with this dramatic problem. Oxyprem’s team is developing the most accurate sensors for measuring the oxygen in premature babies brains. Because the quantity of oxygen in the brain in these premature birth cases is of crucial importance, the high precision of these sensors can prevent and avoid many health problems and deaths caused by oxygen deficiency.
Cardiovascular disease statistics present another tragic situation. With 17.9 million, cardiovascular disease is the leading cause of death and 2.1 million patients receive cardiovascular implants every year. We are proud collaborators of LIFEMATRIX, a project which can make a huge impact and be of great help for achieving the SDG3 goal. LIFEMATRIX unique engineering tissue-based technology tackles drawbacks not solved yet in medicine, as the replacement tissue they create “will be compatible with every patient, regenerate and grow with the recipient”.
These two innovative companies represent a small sample of innovative companies that put faith in a future with better health conditions for everyone. We have also worked in projects together with MYCO SOLUTIONS, ALITHEA GENOMICS, DATAHOW and NIUM among others, all belonging to a new breadth of companies and startups with a sustainable and social mission.
Do you work with technologies that can make an impact on SDG3?
Are you a startup addressing UN’s SDGs?
Please, reach out to us! We will be happy to help bring game-changing impactul technologies to reality.
